18 /100
LOW RISK
Score updated Jul 14, 2026

IONS — Ionis Pharmaceuticals, Inc. Dilution Risk Tracker

Track IONS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IONS — Get alerts when the score changes →

As of July 14, 2026, Ionis Pharmaceuticals, Inc. (IONS) has a DilutionWatch DilutionScore of 18/100, rated LOW dilution risk. Ionis Pharmaceuticals, Inc. has a market capitalization of $12.64B, 165.26M shares outstanding, 496 institutional holders tracked. Key dilution vectors include 4.25M outstanding warrants, approximately 19 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for IONS.
🔔 Track IONS — Get forecast alerts →

💹 Market Data

Market Cap$12.64B
Shares Outstanding165.26M
Float163.98M
Cash$1.92B
Debt$1.76B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 7.8% shares (2026Q1 vs prior)
496 institutional holders · 196.83M shares
#1 FMR LLC 24.56M shares
#2 Capital World Investors 21.19M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 14.24M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest17.43M
Days to Cover7.3
% of Float10.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for IONS Shareholders

Ionis Pharmaceuticals, Inc. (IONS) has a DilutionScore of 18/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch tracks 4.2M outstanding warrants for IONS. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for IONS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for IONS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track IONS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IONS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for IONS
📊 IONS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IONS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.